The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of cataplexy or excessive ...

Lawmakers review video of a September strike that killed two survivors as the Pentagon carries out another suspected drug ...

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.

The FDA has accepted for Priority Review the NDA for baxdrostat for the add-on treatment of uncontrolled or treatment resistant hypertension in adults.

FDA accelerates re-review of Vanda's tradipitant and begins label talks, keeping its motion sickness drug on track for key 2025 decisions.

Review of recent advances in biomimetic drug delivery for rheumatoid arthritis, highlighting targeted nanomedicine strategies ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 ...

So the boat was probably headed to Trinidad, or another Caribbean country. Then it was supposedly heading straight to the United States. Well, maybe not straight. But the drugs were coming here ...

This review systematically examines the integration of machine learning (ML) and artificial intelligence (AI) in nanomedicine ...

Sonrotoclax has received FDA priority review for relapsed or refractory mantle cell lymphoma, indicating potential substantial treatment improvement. The BGB-11417-201 study demonstrated significant ...